Shopping Cart
- Remove All
Your shopping cart is currently empty
(S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent inhibitor of CDKs capable of crossing the blood-brain barrier. It exhibits neuroprotective effects and holds potential for use in stroke research.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 4-6 weeks | |
| 50 mg | $1,980 | 4-6 weeks | |
| 100 mg | $2,500 | 4-6 weeks |
| Description | (S)-Roscovitine ((S)-Seliciclib; (S)-CYC202) is a potent inhibitor of CDKs capable of crossing the blood-brain barrier. It exhibits neuroprotective effects and holds potential for use in stroke research. |
| Targets&IC50 | CDK7:≤1 μM, CDK2:≤1 μM, CDK5:≤1 μM, CDK9:≤1 μM, CDK1:≤1 μM |
| In vivo | In an animal model study using 20-25 g, P60 male C57 b/6 mice, '(S)-Roscovitine' (25 mg/kg; i.p.; administered 15 minutes before and 1 hour after permanent middle cerebral artery occlusion [pMCAo]) demonstrated neuroprotective effects. The treatment resulted in a reduction of the total infarct volume in this model. |
| Synonyms | (S)-Seliciclib, (S)-CYC202 |
| Molecular Weight | 354.45 |
| Formula | C19H26N6O |
| Cas No. | 186692-45-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.